Why Steris (STE) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Is Steris (STE) Up 1% Since Last Earnings Report?
Steris (STE) reported earnings 30 days ago. What's next for the stock?
Why Steris (STE) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Steris (STE) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Reasons to Retain STE Stock in Your Portfolio for Now
STERIS' Healthcare and AST segments post solid gains and milestones, but FX volatility, tariffs and global macro pressures threaten earnings variability.
STERIS Q4 Earnings Call Highlights
STERIS NYSE: STE reported a stronger fiscal 2026 overall despite a lighter fourth quarter, with executives pointing to record annual revenue, resilient procedure demand and continued pricing gains, while also outlining expectations for mid- to high-single-digit growth in fiscal 2027.
STE Q4 Earnings & Revenues Miss, Stock Dips in Aftermarket Trading
STERIS posts Q4 adjusted EPS of $2.83 and revenues of $1.59 billion, both slight misses; shares dip after hours despite broad growth and FY27 guidance.
STERIS plc (STE) Q4 2026 Earnings Call Transcript
STERIS plc (STE) Q4 2026 Earnings Call Transcript
Steris (STE) Q4 Earnings and Revenues Miss Estimates
Steris (STE) came out with quarterly earnings of $2.83 per share, missing the Zacks Consensus Estimate of $2.86 per share. This compares to earnings of $2.74 per share a year ago.
STERIS' Q4 Earnings on Deck: What's in Store for the Stock?
STERIS plc STE is scheduled to release fourth-quarter fiscal 2026 results on May 12, after market close.
Is This the Right Time to Hold STERIS Stock in Your Portfolio?
STE rides on strong Healthcare and AST growth, but FX swings, tariffs, and rising costs cloud the outlook for investors.
Cinctive Capital Management LP Has $4.61 Million Stake in STERIS plc $STE
Cinctive Capital Management LP lowered its position in STERIS plc (NYSE: STE) by 12.8% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 18,615 shares of the medical equipment provider's stock after selling 2,741 shares during the period. Cinctive Capital Management
